American Society for Gastrointestinal Endoscopy

American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors

2025NationalGastrointestinal endoscopy

United States

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full guideline, as published823 KBOpen in a new tab Download

Source and rights

Published by Gastrointestinal endoscopy, 2025. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

linkinghub.elsevier.com/retrieve/pii/S0016-5107(24)03669-1

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Organisation: American Society for Gastrointestinal Endoscopy
Published: 2025
Applies to: 🇺🇸 United States
Scope: National
Journal: Gastrointestinal endoscopy
DOI: 10.1016/j.gie.2024.10.057
PubMed: 39892967
Added to Prognia: 22 July 2026

Quality measures in the design, conduct, and reporting of endoscopic researchAmerican Society for Gastrointestinal Endoscopy (ASGE) [2-4] · 2026Added 26 Jul 2026PodcastInfographic